Shantha Biotechnics is a leading Indian Biopharma company engaged in development, manufacture and commercialization of human health care products. It is the first Indian biotech company to produce drugs by recombinant technology. Some of its reputed brands include Interferon alpha 2b, streptokinase, and a recombinant hepatitis-B vaccine. The company is currently focusing its R&D in the development of generic biologicals, novel therapeutic antibodies and Infectious diseases.
The company believes in creating a congenial work environment and follows an open door policy wherein employees can directly contact their superiors with work related problems at any point of time.